Tech millionaire Steve Kirsch went from covid trial funder to It does not matter how many lives will be saved. Some countries dont have fluvoxamine so this is the alternative. There are 4 outpatient studies that have been done (2 at WashU (see. 707. While he declined a phone interview, Boulware was recently the subject of a Mother Jones article about the harassment hes received for his research on hydroxychloroquine and ivermectin. We could have saved a lot of lives. While YouTube has repeatedly taken down the full video of the DarkHorse episode, various clips have been watched over 4 million times, and the full audio remains available on Spotify. Immediately after the results of the first fluvoxamine trial were releasedbut before they were published in a peer-reviewed journalhe wrote a post on Medium.com called The Fast, Easy, Safe, Simple, Low-Cost Solution to COVID That Works 100% of the Time That Nobody Wants to Talk About.. 95% confidence effect size is 75% or more. You will be wired for 24 hours if you dont heed my advice. All can merit a fluvoxamine prescription based on traditional diagnoses. Now weve lost the high ground, Morris told me. reach out to us at Food/drugs to avoid while on fluvoxamine. The Lancet paper showed that if you were treated early enough and took the drug as prescribed (it only works if you take it), it was shown to reduce your chance of death by 12X making it far more effective than any other drug for COVID. Always be self aware when using fluvoxamine. The NIH wrote a bullshit rejection because the FDA told them not to approve it. The data is there in plain sight for anyone to see today. . Completely avoid caffeine, alcohol, tylenol, and benadryl. Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008 Google Docs This is a more comprehensive look at the key evidence supporting fluvoxamine: Fluvoxamine for COVID-19 That was a lie. There are at least eight mechanisms of action that we think contribute to the effectiveness of this drug. . I have never heard of a case it didn't work. Dr. Seftel's paper has been accepted for publication and will appear in OFID in early February. Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals Fluvoxamine, COVID, pandemic, . If you cant get a prescription for COVID, then perhaps you have OCD? Doctors have no excuse for not prescribing. It is not unusual to be wary of developing science, or wrong to be skeptical of pharmaceutical companies. The man who ran Risperdal sales, Alex Gorsky, is now CEO of Johnson & Johnson. If you cant get a prescription for COVID, then perhaps you have OCD? See my article on treatments. Links to evidence about fluvoxamine including the public data repository. An MIT Technology Review investigation recently revealed how images of a minor and a tester on the toilet ended up on social media. Why the FDA should grant an EUA for fluvoxamine immediately, a brilliant op-ed in the Wall Street Journal, "Too much caution is killing COVID patients. As of January 18, 2021, the CDC estimates that 90,000 Americans will die from COVID in just the next 3 weeks. If it isn't fluvoxamine preventing hospitalization and long-haul COVID, then if you find what it is, you win. So it was both obvious and convincing the difference between the groups to the workers and the track management. Fluvoxamine for COVID: what you need to know - Substack this is NOT about the science. But the best way to help people is through rigorous trials that show what drugs help which people, and at what doses and timesnot by basing entire protocols on incredibly limited evidence. There were IRB rules that required the 65 patients to be listed in the diagrams and charts. NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. Most recent articles first. iRobot said it had consent to collect this kind of data from inside homesbut participants say otherwise. 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology Both of them encouraged anyone reading this article to get vaccinated. Be warned!. He told me that while he and his family got vaccinated as soon as they were eligible, he got the idea that vaccines are dangerous from a man he hired to clean his carpets, who got very sick after receiving the vaccine. After several failed attempts to stop the progression of his disease, he designed his own protocol for chemotherapy and doctor-shopped to find an oncologist who would give it to him. Steve Kirsch is a Silicon Valley philanthropist. In it, he claimed mRNA vaccines kill one in 5,000 recipients and dramatically increase the rate of miscarriages. (PDF) Kaplan Textbook of Psychiatry JL copy - Academia.edu - Share research Yeah, its possible, he told mehe also says that he has regularly seen Kirsch manipulate evidence so that it seems to support claims that are, in reality, baseless. Proxalutamide and fluvoxamine pushers and the early treatment grift. The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. Items included in the Television News search service. Note that some of these articles are inaccurate. Ive talked to doctors who are extremely familiar with the drug and all the trial results and they would prescribe it to their patients. Its all about NIH saying it is OK. . 21. He has been a medical philanthropist for more than 20 years. Tech Tycoon Dangled a COVID CureThen Went Full Anti-Vaxxer - Yahoo! News Im sorry to sound so cynical. Vitamin D, NAC, betadine, aspirin, and Nigella sativa are all super cheap, effective, and available without a prescription. Steve Kirsch: Vaccine Killing Millions, Treatments, VAERS, 5-Month Death Signal, Mystery Clots Embed 1.15K 'This Has Cost Millions of Lives': Steve Kirsch on Suppression of Repurposed Drugs and a Spike in Deaths 5 Months After Vaccine Rollout American Thought Leaders AMERICAN THOUGHT LEADERS JAN JEKIELEK Show more Loading comments. Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. Medicine has been transformed to doing whatever the NIH/FDA says, regardless of how many lives will be lost. They were all given the drug soon after symptoms and the placebo group was pure in that they were not taking any COVID drugs. The anecdotal data of 100% success rates is further icing on the cake. My publicly shared concerns regarding the safety of the COVID-19 vaccines may have had a negative impact on my company, M10. While these are stunning results, less than a dozen doctors in the US are prescribing fluvoxamine today. thinks it should be used (and that the NIH is wrong for waiting for more clinical trials). committee votes 11-2 that the evidence is not adequate to demonstrate a net health benefit for molnupiravir over symptomatic care alone; Paxlovid and fluvoxamine receive more favorable votes, This site requires JavaScript to run correctly. Steve wanted to say, Look, Ive got all these famous [infectious disease] docs and researchers, and they all say give fluvoxamine a chance, Judith Feinberg, one of the former CETF advisory board members and vice chair of research at the West Virginia University School of Medicine, told me. It was recommended back in January 2021 by a key opinion leader (KOL) panel to be used, but it took a year for the KOL meeting notes to be published because they were rejected by 10 journals. But how many did it help? But not 150K. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. 90,000 people don't have to die in the next 3 weeks. Note: normally I have lots of hyperlinks to all the sources, but Im pressed for time. They were all given the drug soon after symptoms and the placebo group was pure in that they were not taking any COVID drugs. So the drug had no chance of working (since there were no events), so the trial was stopped for futility, NOT because the drug doesnt work. The NIH never did a risk benefit analysis of this drug. Have the drug on hand. $1M reward: Do we need more data re: Fluvoxamine for COVID-19? As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. So check the side-effects list to be familiar with which side-effects are associated with which drug so if you have a side-effect, youll know which drug to reduce or eliminate. The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! . After one or two conversations like that, I got tired of arguing, so I started avoiding his calls, she said. 19 In addition, several . Skirsch.io site visitors volume is 1,957 unique day-to-day guests and their 3,914 pageviews. - Quora, Heres presentation I gave at the re-open California Conference on January 9,2021: How to fix the problemHow to fix the problem Steve Kirsch Executive DirectorCOVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008Google Docs[https://docs.google.com/presentation/d/1-A4y78wv3tTPmVu57FOabY6j-MJbPwMGojKwZfaCkAs/. Antidepressant fluvoxamine could keep mild COVID-19 from worsening Why not fluvoxamine? NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. Fluvoxamine is way better than Molnupiravir, but the NIH doesnt approve drugs on effectiveness. skirsch.io Steve Kirsch Home page. A few months ago, Kirsch suddenly stopped promoting hydroxychloroquineeven scrubbing it from the CETFs official list of trials it has funded. The 50mg BID dose was quite effective, but it has to be started early (as soon as symptoms start). So check the side-effects list to be familiar with which side-effects are associated with which drug so if you have a side-effect, youll know which drug to reduce or eliminate. Los Altos Hills resident Steve Kirsch funded research into the drug fluvoxamine as a treatment for COVID-19. Kirsch said that his attempts to promote fluvoxamine are being curtailed. Steve Kirsch is baffled. Online Status. Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. . He might be a good snake oil salesman., I experienced this myself when, on one call, we discussed several studies. Reason is the hospital gets release from liability if they follow NIH guidelines. Quick Summary . Jeffrey Morris, director of biostatistics at the University of Pennsylvania Perelman School of Medicine, has made debunking Kirschs claims something of a hobby. Steve Kirsch On COVID Early Treatment and Censorship - YouTube Kirsch told me that meta-analyses are a higher level of evidence than randomized controlled trials. When I responded that meta-analyses are only as good as the data they are based on, he said Id like to understand your source on that, because I cant find a source that says a phase 3 trial is greater evidence than a meta-analysis., When you characterize me, you need to say that Steve Kirsch doesn't go with majority votes on interpreting data.. And he wont talk to you either if you ask nosy questions like Cliff, my risk benefit analysis shows you should be rushing to recommend this drug. Doctors who are most familiar with the drug would prescribe it to their patients. Although there is evidence that fluvoxamine can prevent clinical worsening and the need for hospitalizations in outpatients with early covid-19, I have seen no good evidence that fluvoxamine is useful as a substitute for the vaccines, co-investigator Angela Reiersen wrote to me. Steve Kirsch Nov 5, 2021 145 92 Here are the key things you should know about fluvoxamine for COVID: It works. Do the NIH and WHO COVID treatment recommendations need to be fixed? May 16, 2022. Even though they spent only 45 minutes and just reviewed the 2 clinical studies and some plausible mechanisms of action (and ignored anecdotal evidence and multiple retrospective trials, all of which were supportive), after the meeting they voted overwhelmingly (11 to 5 with 4 being neutral) in favor of having doctors talk to their patients about using fluvoxamine if they have COVID using a "shared decision making" process. fluvoxamine - Steve Kirsch Home page Steve Kirsch. Steven Todd Kirsch is an American entrepreneur. Its really, really common for a small effect, something that looks exciting, to be a statistical fluke when you look at a larger population. He is very smart, and knows that he is very smart, and sometimes he behaves like he thinks he's the smartest guy in the room, whether he is or isn't., Kirschs response was to take his name off articles hed written about vaccine deaths, changing the authorship to VaccineTruth., On July 1, he tweeted from his personal account, My publicly shared concerns regarding the safety of the COVID-19 vaccines may have had a negative impact on my company, M10. At the beginning of the COVID-19 pandemic, Steve Kirsch created the COVID-19 Early Treatment Fund (CETF) to finance trials of off-patent drugs in an attempt to find a potent treatment that had been staring us in the face. My website www.skirsch.io has tons of info on fluvoxamine with all the links. including the very promising Fluvoxamine. Enter the email address you signed up with and we'll email you a reset link. In November, CETF gave the group an additional $500,000 for a phase 3 clinical trial that might show conclusive proof of efficacy. About - vacsafety.org About 10 minutes on the internet will show you those two gentlemen, who have appeared together, have been extensively fact checked for false or misleading claims or misuse of VAERS reporting and other data. This is what the Seftel trial at Golden Gate fields used. Note that some of these articles are inaccurate. As a health care journalist, I started off firmly in the wait-and-see camp on mRNA vaccines. The drug was widely prescribed as a covid treatment for much of 2020, based on anecdotes and flawed studies. Can I see your risk-benefit analysis?. Theres nothing there.). Thanks for working tirelessly to help others. Steve Kirsch - Wikipedia It was recommended back in January 2021 by a key opinion leader (KOL) panel to be used, but it took a year for, because they were rejected by 10 journals. NIH is still unsure whether fluvoxamine should be used to treat COVID (article I did after the TOGETHER trial). Stopping the meds will return you to your normal self. S1R can essentially turn off IRE1, so IRE1 will not activate XBP1, so that the cytokine production will decrease. So much for evidence-based medicine. Kirsch and his group received a fresh wave of attention off hopeful trials of the antidepressant fluvoxamine, which ultimately won him a spot on 60 Minutes in March. Is that really true? He's founded 7 companies, 2 with billion dollar valuations. Sage Hana. Doctors wait for government permission (EUA or added to the NIH guidelines) before using a drug. We didnt come up with better mouse technology than Microsoft did. Steve Kirsch and Dr. Robert Malone, MIT COVID-19 Postgame - Substack It's hard to ignore this lecture in explaining why the drug is so effective. A very short op-ed arguing for using fluvoxamine against COVID. He felt like he in good conscience had to speak out about covid, and so he made the decision to separate himself from M10, says Char, who has known Kirsch since the 1980s. Current Early Covid treatment from Steve Kirsch (infection, doctor Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), a class of anti-depressants, mostly prescribed for people suffering from an obsessive-compulsive disorder. The choice couldn't be more clear cut. customer-service@technologyreview.com with a list of newsletters youd like to receive. It is very important to educate doctors because most people rely on their doctors for advice. Pennsylvania Senator Doug Mastriano Hosts Expert Panel on Medical But the potential upsides. The medical community doesnt care about saving lives. So you can address your OCD and if you get COVID, youll can up the dose. But an Editor's Note urged physicians to treat this as a hypothesis and not as a basis for clinical decision-making. Also, for people who cant tolerate fluvoxamine for whatever reason (nausea, jittery, etc), this is the alternative. The track management was so impressed, they asked for prescriptions. Nobody in the medical community is speaking out about how hypocritical the medical community is for ignoring the positive Phase 3 trial results and instead following whatever the NIH or FDA says. Debunking Steve Kirsch's latest claims about covid vaccine deaths The reason is pure corruption. My experience is very typical. Fluvoxamine has at least a 30% hospitalization and death benefit. Physicians who use the drug for COVID now swear by it. Jan 17. Those days are gone. . O, Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19 | Blood Advances | American Society of Hematology, Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008, Fluvoxamine for COVID-19 Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008, Drug Repurposing Research Leads to Potentially Game-Changing Treatment to Prevent Clinical Deterioration in Outpatients With COVID, The Covid-19 Early Treatment Fund was launched to provide funding for research in order to, Steve Kirschs answer to What is the current treatment for Covid-19? There is absolutely no evidence that either one of these claims is true, as Morris has carefully documented. When the pandemic started, he created the COVID-19 Early Treatment Fund (CETF) to fund researchers working on repurposed drugs including fluvoxamine which reduces death from COVID by a factor of 12. That trial has now been completed, and the researchers are analyzing their data. One of the first CETF grants was to investigate the antimalarial hydroxychloroquine. Press - treatearly.org The NIH did nothing despite the fact the that NIH, FDA, CDC, and academic institutions participated in the panel. TV NEWS : Search Captions. Borrow Broadcasts : TV Archive : Internet Waiting months for the phase 3 trial to complete is nuts. Dosage there is 30mg once a day. The premise made sense: Most experts were predicting vaccines would take years, while finding helpful drugs with known safety profiles could shortcut the approval process. Fluvoxamine To Treat COVID: what you need to know - CoronaFraud.com